Job Posted: 18 Jan 2017

Senior Research Associate / Market Access - UK & Ireland

£50,000 - £60,000| Sheffield| Permanent

Iím partnering with one of the largest privately owned health economic and outcomes research (HEOR) consultancies in the world. With head offices in Sheffield and people in the UK, Denmark, India, Ireland and the Netherlands. They are also currently opening an office in the US, which means that there are opportunities for international placements.

Your responsibilities:

Developing market access deliverables, including:

  • Clinical sections of reimbursement dossiers for HTA bodies
  • Value dossiers and value stories to support the case for new products
  • Systematic literature reviews of clinical evidence
  • Posters and abstracts, and manuscripts for peer-reviewed journals

Project and task management

Your skills:

  • A relevant BSc/BA or post graduate qualification in biochemistry, biology, biomedical science or a closely related field
  • At least 2 yearsí experience in medical writing in a consultancy or pharmaceutical environment
  • Research and analysis skills
  • Proven ability to manage projects to within timelines, budget and scope

With unrivaled industry knowledge and excellent links with hiring managers in Health Economics, Outcomes Research and Market Access throughout the UK, Europe and across the world, we would be delighted to speak with you about the role you are looking for. Call +44 (O)1293 584 300 or email ****************************** for a confidential discussion about your options for progression.

Keywords: Market Access, MA, MAPR, MAPOR, HTA, Health Technology Assessment, Global Value Dossier, GVD, VD, London, Pricing, Pricing & Reimbursement, Market Access, HEOR, HEPRA, Health Economist, health economics, outcomes research, pricing, reimbursement, market access, Pharmaceutical, pharma, leading pharma, Head of Health Economics, Director, senior, line management, Pricing, PRO, pharmacoeconomics, Germany, UK, France, Switzerland, global, Europe, European, HTA, markov, decision tree, Health Technology, NICE, NHS, systematic literature reviews, retrospective database analyses, prospective studies, cost-effectiveness, budget impact models, HEOR, HEPRA, Health Economist, line management, health economics, outcomes research, pricing, reimbursement, market access, Pharmaceutical, pharma, leading pharma, Head of Health Economics, Director, senior, line management, Pricing, PRO, pharmacoeconomics, Germany, UK, France, Switzerland, global, Europe, European, HTA, markov, decision tree, Health Technology, NICE, NHS, systematic literature reviews, retrospective database analyses, prospective studies, cost-effectiveness, budget impact